Skip to main content
. 2013 Apr 20;139(7):1229–1240. doi: 10.1007/s00432-013-1436-y

Table 3.

Predictive factors of pCR/0 according to the multivariate logistic regression model

Variables pCR/0
OR (95% CI) P value
Molecular subclasses
 HER2+, ER−, PgR−* versus HER2+, ER+ and/or PgR+° 4.03 (1.85–8.74) <0.0001
Trastuzumab duration in NST
 >12 weeks versus ≤12 weeks 2.40 (1.10–5.22) 0.03

HER2 Human epidermal growth factor type 2, ER estrogen receptors, PgR progesteron receptors, OR odds ratio, CI confidence intervals

° Luminal B/HER2+, * nonluminal/HER2+